Collagen Peptides Improve Blood Sugar Control in Mice Through GLP-1 and Other Pathways
Oral collagen hydrolysates improved glucose tolerance in mice by both stimulating GLP-1 and enhancing insulin secretion through a separate, GLP-1-independent mechanism.
Quick Facts
What This Study Found
Collagen hydrolysates (broken-down collagen peptides) improved blood sugar control in mice through two distinct mechanisms: they inhibited glucose absorption in the intestine (partially through GLP-1) and they enhanced insulin secretion (independent of GLP-1). The collagen peptides also inhibited DPP-IV enzyme activity and stimulated GLP-1 secretion in lab tests. Blocking the GLP-1 receptor only partially reversed the glucose-lowering effect and actually enhanced the insulin secretion boost, confirming that collagen peptides work through multiple pathways.
Key Numbers
How They Did This
Researchers first tested collagen hydrolysates in the lab for DPP-IV inhibition and GLP-1 secretion. They then gave collagen peptides orally to normal C57BL mice and measured blood sugar response using oral and intraperitoneal glucose tolerance tests. To tease apart the mechanisms, they pretreated some mice with exendin 9-39 (a GLP-1 receptor blocker). They also measured insulin secretion when collagen was given 45 minutes before glucose, and tested gastric emptying rates.
Why This Research Matters
Collagen supplements are hugely popular for skin and joint health, but this study reveals they may also improve blood sugar control — through the same GLP-1 pathway targeted by blockbuster diabetes drugs like semaglutide. The finding that collagen peptides work through both GLP-1-dependent and GLP-1-independent mechanisms suggests they could complement existing diabetes treatments.
The Bigger Picture
The intersection of collagen supplements and metabolic health is a new research frontier. With hundreds of millions of people taking collagen supplements for cosmetic reasons, discovering that these peptides also engage the GLP-1 system — the most important drug target in modern obesity and diabetes treatment — is potentially significant. If confirmed in humans, it would add metabolic benefits to an already popular supplement category.
What This Study Doesn't Tell Us
This study used normal (non-diabetic) mice, so results may differ in diabetic animals or humans. The specific peptide sequences responsible for the effects weren't identified. The collagen hydrolysate is a mixture of many peptides, making it unclear which ones drive each mechanism. No human clinical data was generated.
Questions This Raises
- ?Do commercial collagen supplements contain the right peptide profile to produce these blood sugar effects in humans?
- ?What specific peptide sequences within collagen hydrolysates are responsible for the DPP-IV inhibition and GLP-1 stimulation?
- ?Would collagen peptides enhance the effects of GLP-1 drugs when taken together?
Trust & Context
- Key Stat:
- Dual mechanism Collagen peptides lowered blood sugar through both GLP-1-dependent intestinal glucose blocking and GLP-1-independent insulin secretion enhancement
- Evidence Grade:
- This is a preclinical study in normal mice combining in vitro and in vivo experiments. It provides mechanistic insight but has not been validated in diabetic models or human clinical trials.
- Study Age:
- Published in 2016. Interest in collagen peptides' metabolic effects has grown since, with the GLP-1 connection becoming more relevant as GLP-1 drugs have gained popularity.
- Original Title:
- Oral Administration of Collagen Hydrolysates Improves Glucose Tolerance in Normal Mice Through GLP-1-Dependent and GLP-1-Independent Mechanisms.
- Published In:
- Journal of medicinal food, 19(9), 836-43 (2016)
- Authors:
- Iba, Yoshinori, Yokoi, Koji, Eitoku, Itsuka, Goto, Masaki, Koizumi, Seiko, Sugihara, Fumihito, Oyama, Hiroshi, Yoshimoto, Tadashi
- Database ID:
- RPEP-02973
Evidence Hierarchy
Frequently Asked Questions
Can collagen supplements help with blood sugar control?
This mouse study found that collagen peptides can improve glucose tolerance by stimulating GLP-1 and enhancing insulin secretion. However, these effects haven't been confirmed in humans, and it's unclear whether typical collagen supplement doses would produce similar results.
How do collagen peptides relate to GLP-1 drugs like Ozempic?
Collagen hydrolysates were found to inhibit DPP-IV (the enzyme that breaks down GLP-1) and stimulate GLP-1 secretion — affecting the same pathway targeted by GLP-1 drugs. However, the effects would likely be much weaker than pharmaceutical GLP-1 agonists.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02973APA
Iba, Yoshinori; Yokoi, Koji; Eitoku, Itsuka; Goto, Masaki; Koizumi, Seiko; Sugihara, Fumihito; Oyama, Hiroshi; Yoshimoto, Tadashi. (2016). Oral Administration of Collagen Hydrolysates Improves Glucose Tolerance in Normal Mice Through GLP-1-Dependent and GLP-1-Independent Mechanisms.. Journal of medicinal food, 19(9), 836-43. https://doi.org/10.1089/jmf.2016.3711
MLA
Iba, Yoshinori, et al. "Oral Administration of Collagen Hydrolysates Improves Glucose Tolerance in Normal Mice Through GLP-1-Dependent and GLP-1-Independent Mechanisms.." Journal of medicinal food, 2016. https://doi.org/10.1089/jmf.2016.3711
RethinkPeptides
RethinkPeptides Research Database. "Oral Administration of Collagen Hydrolysates Improves Glucos..." RPEP-02973. Retrieved from https://rethinkpeptides.com/research/iba-2016-oral-administration-of-collagen
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.